Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide and factor XIII for refractory pleural effusion after pediatric cardiac surgery
jRCT1031200009Active, not recruiting
- Start
- Oct 2014
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of octreotide and catridecacog in pleural effusion and chylothorax (2 arms). Primary endpoint: Thoracic drain removal by day 10 after medical treatment. Started Oct 2014; status: active, not recruiting.
02
Drugs
octreotidecatridecacog
03
Conditions
pleural effusionchylothorax
Beyond the preview
Go deeper on jRCT1031200009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031200009.